- Research works
- 96 ▲ 611% vs 2013–17
- Citations
- 1.1k 11.4 per fractional work
- Top-10% rate
- 25.9% record average 16.5%
- Open access
- 84% world 28%
Not ranked overall: Seqirus (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
What does Seqirus (United States) specialise in?
Where its research is concentrated relative to its size: Epidemiology takes 38.0× the share of its output that it takes of world research.
- EpidemiologySubfield · 26.0 works38×
- MedicineField · 31.8 works3.4×
- Health SciencesDomain · 32.3 works2.9×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.3×. Every wedge is a field page.
- Immunology and Microbiology 6.3×
- Medicine 3.4×
- Mathematics 2.4×
- Pharmacology, Toxicology and Pharmaceutics 2.3×
- Chemistry 1.0×
- Biochemistry, Genetics and Molecular Biology 0.9×
- Social Sciences 0.9×
- Dentistry 0.7×
- Agricultural and Biological Sciences 0.7×
- Economics, Econometrics and Finance 0.6×
- Health Professions 0.3×
- Materials Science 0.1×
- Environmental Science 0.1×
- Engineering 0.0×
Which keywords describe research at Seqirus (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Pathogenesis, Pandemic, Respiratory, Genomics, Virus, H1N1 and Influenza.
- Pedagogy
- transmission dynamics
- COVID-19
- antibody
- ACE2 Receptor
- Community-Acquired Pneumonia
- Respiratory Infections
- Antimicrobial Resistance
- Immunity
- COVID-19 Vaccine
- Vaccine
- Human Metapneumovirus
- Influenza
- Virus
- Respiratory
- Pathogenesis
- Epidemiology
- Pandemic
- Genomics
- H1N1
- Vaccine Development
- Respiratory Syncytial Virus
- Social Media
- Vaccine Hesitancy
- Coronavirus
- Infectious Diseases
- SARS-CoV-2
- Pneumococcal Conjugate Vaccine
- Immune Response
- spike protein
- Modeling
- Sustainability
- Science Education
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 33 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 33 words, with their numbers
- Epidemiology29▲ 15×16 topics
- Pathogenesis15▲ 62×6 topics
- Pandemic15▲ 29×3 topics
- Respiratory13▲ 283×2 topics
- Genomics13▲ 91×2 topics
- Virus13▲ 281×2 topics
- H1N113▲ 867×1 topic
- Influenza13▲ 641×1 topic
- Vaccine Development11▲ 90×5 topics
- Human Metapneumovirus10▲ 478×1 topic
- Respiratory Syncytial Virus10▲ 478×1 topic
- Vaccine4▲ 21×6 topics
- Social Media4▲ 5.5×2 topics
- COVID-19 Vaccine4▲ 104×1 topic
- Vaccine Hesitancy4▲ 112×1 topic
- Immunity3▲ 15×3 topics
- Coronavirus3▲ 26×2 topics
- Antimicrobial Resistance2▲ 25×2 topics
- Infectious Diseases2▲ 15×3 topics
- Respiratory Infections2▲ 40×2 topics
- SARS-CoV-22▲ 14×4 topics
- Community-Acquired Pneumonia2▲ 134×1 topic
- Pneumococcal Conjugate Vaccine2▲ 134×1 topic
- ACE2 Receptor2▲ 17×2 topics
- Immune Response2▲ 7.0×6 topics
- antibody2▲ 37×1 topic
- spike protein2▲ 37×1 topic
- COVID-192▲ 2.5×3 topics
- Modeling1▲ 11×1 topic
- transmission dynamics1▲ 40×1 topic
- Sustainability1◆ 0.92×2 topics
- Pedagogy1▲ 4.2×1 topic
- Science Education1▲ 33×1 topic
Which research topics does Seqirus (United States) publish most on?
By volume in 2022–2025: Influenza Virus Research Studies, Respiratory viral infections research, Vaccine Coverage and Hesitancy and Pneumonia and Respiratory Infections.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Influenza Virus Research Studies Epidemiology 13 works
- 2 Respiratory viral infections research Epidemiology 10 works
- 3 Vaccine Coverage and Hesitancy Health 4 works
- 4 Pneumonia and Respiratory Infections Epidemiology 2 works
- 5 SARS-CoV-2 and COVID-19 Research Infectious Diseases 2 works
- 6 COVID-19 epidemiological studies Modeling and Simulation 1 works
- 7 Chemistry Education and Research Education 1 works
- 8 Viral Infections and Outbreaks Research Infectious Diseases 1 works
- 9 Immune responses and vaccinations Immunology 1 works
- 10 Immunotherapy and Immune Responses Immunology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Seqirus (United States)'s research output changed?
Output in 2018–2022 was 611% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Cambridge
- Harvard University
- Massachusetts Institute of Technology
- Center for Astrophysics Harvard & Smithsonian
- National Bureau of Economic Research
- IIT@MIT
- World Wide Web Consortium
- Broad Institute
- Smithsonian Astrophysical Observatory
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.